Status:

RECRUITING

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

Lead Sponsor:

Sohag University

Conditions:

Hepatic Encephalopathy

Eligibility:

All Genders

18+ years

Brief Summary

assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcom...

Detailed Description

sample size calculation will be performed based on anticipated incidence rates of HE and variability in serum albumin levels, aiming for a study population of 100-150 patients to achieve adequate stat...

Eligibility Criteria

Inclusion

  • patients aged \>18 years.
  • Confirmed chronic liver disease (by imaging ,
  • liver function tests , and clinical history).
  • Diagnosed with hepatic encephalopathy based on clinical criteria.
  • Patients able to provide informed consent.

Exclusion

  • Patients age less than 18 years old
  • Acute liver failure.
  • Chronic renal failure on dialysis.
  • Pregnant women.
  • Patients with active malignancy.

Key Trial Info

Start Date :

March 12 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 12 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06953921

Start Date

March 12 2025

End Date

September 12 2025

Last Update

May 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sohag university hospital

Sohag, Egypt